Dr. Travis Stiles, CEO & President
For nearly a decade, Dr. Travis Stiles has exclusively studied the mechanisms underlying regenerative failure in the central nervous system (CNS). His work led to the discovery of a novel therapeutic target for the promotion of neuronal tissue regeneration after CNS damage and/or disease. His work has demonstrated this novel target is a central regulator of the convergence of a diverse array of molecular factors that cause catastrophic failure of neuronal regeneration in the CNS, thereby making it an exciting intervention point for restoring the regenerative capacity of the brain and spinal cord. To best translate his work into clinically viable therapies, Dr. Stiles co-founded Novoron Bioscience, Inc. early in 2013. Since that time Novoron has raised approximately $1.5 MM in NIH grant funding and now holds exclusive licenses from the University of California, San Diego (UCSD) to two intellectual property assets of which Dr. Stiles was the primary inventor. Travis earned a Ph.D. in Biomedical Science from UCSD, a M.A. in Exercise Physiology from the University of the Pacific, and a B.A. in Exercise Science from Willamette University.